IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)

INR 434.5

(7.04%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 22.44 Billion 20.22 Billion 19.62 Billion 16.1 Billion 11.75 Billion 9.41 Billion
Total Current Assets 11.19 Billion 9.2 Billion 10.8 Billion 10.22 Billion 6.7 Billion 4.88 Billion
Cash And Short Term Investments 1.45 Billion 467.7 Million 1.2 Billion 3.36 Billion 1.3 Billion 134.7 Million
Cash and Cash Equivalents 1.42 Billion 13.9 Million 35.6 Million 323.4 Million 280.9 Million 134.1 Million
Short Term Investments 28.8 Million 453.8 Million 1.16 Billion 3.04 Billion 1.02 Billion 600 Thousand
Net Receivables 4.71 Billion 5.07 Billion 5.15 Billion 3.63 Billion 2.92 Billion 2.02 Billion
Inventory 4.24 Billion 3.25 Billion 4.09 Billion 2.95 Billion 1.87 Billion 1.88 Billion
Other Current Assets 779.3 Million 410.7 Million 348.8 Million 274.2 Million 3.52 Billion 2.85 Billion
Total Non-Current Assets 11.24 Billion 11.01 Billion 8.81 Billion 5.87 Billion 5.04 Billion 4.53 Billion
Net PPE 10.21 Billion 8.32 Billion 6.62 Billion 5.6 Billion 4.87 Billion 4.38 Billion
Good Will And Intangible Assets 126.1 Million 88.9 Million 35.5 Million 6.1 Million 5.1 Million 7.4 Million
Good Will - - - - - -
Intangible Assets 126.1 Million 88.9 Million 35.5 Million 6.1 Million 5.1 Million 7.4 Million
Long-Term Investments 662.8 Million 2.48 Billion 2.03 Billion 196.8 Million -500 Thousand 67.9 Million
Tax Assets 45.6 Million 31.3 Million 14.3 Million 20.5 Million 5.04 Billion 4.46 Billion
Other Non Current Assets 197.9 Million 90.1 Million 103 Million 50.4 Million -4.88 Billion -4.38 Billion
Other Assets - - - - - -
Total Liabilities 6.32 Billion 5.14 Billion 5.69 Billion 3.49 Billion 3.62 Billion 4.67 Billion
Total Current Liabilities 5.6 Billion 4.56 Billion 5.13 Billion 2.9 Billion 2.82 Billion 2.56 Billion
Account Payables 4.69 Billion 3.14 Billion 4.09 Billion 2.38 Billion 1.86 Billion 1.2 Billion
Tax Payables - - - 46.6 Million 13.6 Million 44.7 Million
Short Term Debt 327.6 Million 798.1 Million 437.7 Million 9 Million 567.6 Million 941.2 Million
Deferred Revenue 88.5 Million 444.7 Million 392.1 Million 440.8 Million 354.5 Million 403.2 Million
Other Current Liabilities 492.1 Million 177.6 Million 211.3 Million 67.4 Million 39.9 Million 21.8 Million
Total Non Current Liabilities 728.89 Million 581.5 Million 564.2 Million 591.1 Million 797.3 Million 2.1 Billion
Long-Term Debt - - 1.8 Million 18.3 Million 27.3 Million 1.89 Billion
Deferred Revenue Non Current - - 30.1 Million 3.8 Million 5.1 Million 6.5 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 67.49 Million 17.9 Million 500 Thousand 36.8 Million 38.5 Million 45.9 Million
Other Liabilities 1.00 - - - - -
Total Equity 16.11 Billion 15.07 Billion 13.92 Billion 12.6 Billion 8.13 Billion 4.74 Billion
Stock Holders Equity 16.11 Billion 15.07 Billion 13.92 Billion 12.6 Billion 8.13 Billion 4.74 Billion
Common Stock 587.1 Million 587.1 Million 587.1 Million 587.1 Million 568.9 Million 568.9 Million
Retained Earnings 13.24 Billion 12.19 Billion 11.03 Billion 9.71 Billion 5.5 Billion 2.09 Billion
Accumulated other comprehensive income 26 Million 38.9 Million 40.9 Million 46.9 Million -1.26 Billion -914.7 Million
Common Stock Equity 16.11 Billion 15.07 Billion 13.92 Billion 12.6 Billion 8.13 Billion 4.74 Billion
Capital Lease Obligation - 1.8 Million 12 Million 27.3 Million 35 Million -
Total Investments 691.6 Million 2.51 Billion 1.85 Billion 196.8 Million 1.02 Billion 68.5 Million
Total Debt 327.6 Million 798.1 Million 439.5 Million 27.3 Million 594.9 Million 2.84 Billion
Net Debt -1.1 Billion 784.2 Million 403.9 Million -296.1 Million 314 Million 2.7 Billion

Balance Sheet Charts